Literature DB >> 11795760

Spironolactone prescribing in heart failure: comparison between general medical patients and those attending a specialist left ventricular dysfunction clinic.

R McMullan1, B Silke.   

Abstract

We compared the rate of prescription of low-dose spironolactone among patients with heart failure in a general medical inpatient setting and in a specialist left ventricular (LV) dysfunction clinic. 38% of general medical patients and 72% of patients attending the specialist clinic had been prescribed spironolactone. When contraindications were considered, 54% of patients in the general medical group and 77% of patients in the specialist clinic group were appropriately treated in respect of spironolactone prescribing. Patients attending a specialist LV dysfunction clinic are therefore more likely to be treated with low dose spironolactone, an accepted appropriate treatment for heart failure, than those admitted to general medical and acute geriatric units. Improvement in care for patients with CHF may be achieved either by increasing the use of specialist clinics or by better dissemination of evolving evidence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11795760      PMCID: PMC2449242     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  13 in total

1.  Aldosterone antagonism in heart failure.

Authors:  A M Richards; M G Nicholls
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

2.  Drug cuts deaths from heart failure by a third.

Authors:  S Gottlieb
Journal:  BMJ       Date:  1999-07-31

3.  Role of spironolactone in heart failure should be emphasised.

Authors:  J Mapstone; B Houston; M Gogarty
Journal:  BMJ       Date:  2000-09-16

4.  Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients.

Authors:  R J MacFadyen; C S Barr; A D Struthers
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

5.  Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.

Authors:  M H Chin; P D Friedmann; C K Cassel; R M Lang
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

6.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

7.  ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?

Authors:  A P Davie; J J McMurray
Journal:  Postgrad Med J       Date:  1999-04       Impact factor: 2.401

Review 8.  [Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values].

Authors:  L Cserhalmi
Journal:  Orv Hetil       Date:  1998-01-11       Impact factor: 0.540

9.  The use of angiotensin converting enzyme inhibitors in general practice--appropriate or inappropriate?

Authors:  J P Connolly; B Silke; H McGavock; K Wilson-Davies
Journal:  Pharmacoepidemiol Drug Saf       Date:  1998-09       Impact factor: 2.890

Review 10.  Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.

Authors:  A D Struthers
Journal:  J Card Fail       Date:  1996-03       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.